Insmed | INSM

Aktienkurs
111.12
Täglich Wechseln
2.53 2.33%
Monatlich
-12.28%
Jährlich
-29.30%
Q4 Prognose
115.28

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-10-22 FY2026Q3 AM -0.61 -1.75
2026-08-06 FY2026Q2 AM -0.06 -0.75 -1.70
2026-05-07 FY2026Q1 AM -0.76 -0.99 -1.42
2026-02-19 FY2025Q4 AM -1.54 -1.28 -1.32
2025-10-30 FY2025Q3 AM -1.75 -1.34 -1.27



Preis Chg Tag Jahr Datum
BioMarin Pharmaceutical 57.18 -1.26 -2.16% 3.16% 2026-10-02
Cytokinetics 65.60 -0.02 -0.03% 15.15% 2026-10-02
DBV Technologies 10.55 -0.66 -5.89% -18.22% 2026-10-02
Gilead Sciences 144.74 -2.76 -1.87% 28.44% 2026-10-02
Heron Therapeutics 0.35 -0.01 -2.25% -73.64% 2026-10-02
Insmed 111.12 2.53 2.33% -29.30% 2026-10-02
Novartis 141.00 -0.02 -0.01% 6.50% 2026-10-02
Ultragenyx Pharmaceutical 15.22 0.47 3.19% -51.23% 2026-10-02
Regeneron Pharmaceuticals 735.20 0.39 0.05% 22.53% 2026-10-02
Sarepta Therapeutics 17.50 -0.07 -0.40% -22.70% 2026-10-02

Preis Tag Jahr Datum
USND 27191 319.27 1.19% 19.36% 2026-10-02
US2000 2833 26.53 0.95% 14.42% 2026-10-02